Ralimetinib (LY2228820) dimesylate

Selleck Chemicals

Ralimetinib (LY2228820) dimesylate [862507-23-1]

9

Research Use Only

...

Ralimetinib (LY2228820) dimesylate is a novel and potent inhibitor of p38 MAPK with IC50 of 7 nM in a cell-free assay, does not alter p38 MAPK activation. Phase 1/2.

-80°C

51202000